Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Biomarin Pharmaceutical Inc (BMRN)
since 2005 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 1048477.
Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.
Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 4
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2017-06-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 89.70 | 448,500 |
| 2017-06-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-06-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 87.53 | 437,650 |
| 2017-06-01 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-31 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 7,423 | 88.29 | 655,376 |
| 2017-05-31 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 7,423 | 17.33 | 128,640 |
| 2017-05-24 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 88.38 | 441,900 |
| 2017-05-24 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 91.73 | 458,650 |
| 2017-05-17 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-16 | Davis George Eric (EVP, General Counsel) | Option Ex | 1,146 | 14.39 | 16,490 |
| 2017-05-12 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 89.23 | 446,150 |
| 2017-05-12 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-08 | Mueller Brian (SVP, Corporate Controller) | Sale | 7,482 | 92.17 | 689,615 |
| 2017-05-08 | Mueller Brian (SVP, Corporate Controller) | Option Ex | 2,600 | 21.51 | 55,926 |
| 2017-05-08 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 93.17 | 465,850 |
| 2017-05-08 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-05 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 4,486 | 99.00 | 444,114 |
| 2017-05-05 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Option Ex | 4,486 | 33.41 | 149,877 |
| 2017-05-05 | Davis George Eric (EVP, General Counsel) | Sale | 2,500 | 100.34 | 250,852 |
| 2017-05-05 | Davis George Eric (EVP, General Counsel) | Option Ex | 2,500 | 38.59 | 96,475 |
| 2017-05-05 | Meier Richard A | Option Ex | 7,500 | 17.33 | 129,974 |
| 2017-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 99.00 | 495,000 |
| 2017-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-05-02 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 302 | 96.74 | 29,215 |
| 2017-04-27 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 95.72 | 478,600 |
| 2017-04-27 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-04-25 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 94.00 | 470,000 |
| 2017-04-25 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-04-04 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 3,000 | 14.39 | 43,170 |
| 2017-03-29 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 3,890 | 89.15 | 346,793 |
| 2017-03-16 | Davis George Eric (EVP, General Counsel) | Sale | 2,238 | 91.96 | 205,806 |
| 2017-03-16 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 1,989 | 91.96 | 182,908 |
| 2017-03-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 91.96 | 459,799 |
| 2017-03-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 71.33 | 356,650 |
| 2017-03-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 91.42 | 457,100 |
| 2017-03-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-03-13 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 92.68 | 463,400 |
| 2017-03-13 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-03-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 91.09 | 455,450 |
| 2017-03-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-03-09 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 6,000 | 90.18 | 541,080 |
| 2017-03-09 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 6,000 | 17.33 | 103,979 |
| 2017-03-07 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 5,000 | 90.56 | 452,800 |
| 2017-03-06 | Davis George Eric (EVP, General Counsel) | Sale | 1,498 | 93.32 | 139,793 |
| 2017-03-06 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 2,303 | 93.32 | 214,915 |
| 2017-03-01 | Lawlis V Bryan | Sale | 7,500 | 95.00 | 712,500 |
| 2017-03-01 | Lawlis V Bryan | Option Ex | 7,500 | 17.33 | 129,974 |
| 2017-03-01 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 5,000 | 94.50 | 472,500 |
| 2017-02-28 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 30,000 | 94.00 | 2,820,000 |
| 2017-02-28 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 30,000 | 63.10 | 1,893,000 |
| 2017-02-24 | Fuchs Henry J (President, Worldwide R&D) | Sale | 15,000 | 87.99 | 1,319,850 |
| 2017-02-24 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 15,000 | 26.49 | 397,350 |
| 2017-01-26 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 84.00 | 420,000 |
| 2017-01-26 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-01-25 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 5,000 | 84.44 | 422,200 |
| 2017-01-25 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-01-11 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 89.84 | 359,360 |
| 2017-01-11 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2017-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 91.31 | 365,240 |
| 2017-01-10 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2017-01-09 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 5,000 | 90.00 | 450,000 |
| 2017-01-09 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 89.79 | 359,160 |
| 2017-01-09 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2017-01-06 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 87.19 | 348,760 |
| 2017-01-06 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2016-12-30 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 83.35 | 333,400 |
| 2016-12-30 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2016-12-29 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 4,000 | 83.84 | 335,360 |
| 2016-12-29 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 4,000 | 17.33 | 69,320 |
| 2016-11-25 | Fuchs Henry J (President, Worldwide R&D) | Sale | 15,000 | 87.40 | 1,310,985 |
| 2016-11-25 | Fuchs Henry J (President, Worldwide R&D) | Option Ex | 15,000 | 26.49 | 397,350 |
| 2016-11-22 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 69,743 | 85.69 | 5,976,486 |
| 2016-11-22 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 69,743 | 26.49 | 1,847,492 |
| 2016-11-21 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 69,744 | 87.56 | 6,106,505 |
| 2016-11-21 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 69,744 | 26.49 | 1,847,518 |
| 2016-11-18 | Davis George Eric (EVP, General Counsel) | Sale | 5,000 | 90.42 | 452,100 |
| 2016-11-18 | Davis George Eric (EVP, General Counsel) | Option Ex | 5,000 | 38.59 | 192,950 |
| 2016-11-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 41,670 | 90.97 | 3,790,803 |
| 2016-11-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 41,670 | 17.54 | 730,891 |
| 2016-11-09 | Lawlis V Bryan | Sale | 7,500 | 95.00 | 712,500 |
| 2016-11-09 | Lawlis V Bryan | Option Ex | 7,500 | 17.33 | 129,974 |
| 2016-11-09 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 20,000 | 90.61 | 1,812,200 |
| 2016-11-08 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 70,000 | 82.83 | 5,797,820 |
| 2016-11-08 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 70,000 | 21.51 | 1,505,700 |
| 2016-11-07 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 70,000 | 82.52 | 5,776,470 |
| 2016-11-07 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 70,000 | 21.51 | 1,505,700 |
| 2016-10-28 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 60,000 | 81.27 | 4,876,020 |
| 2016-10-28 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 60,000 | 14.39 | 863,400 |
| 2016-10-27 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 60,000 | 81.34 | 4,880,460 |
| 2016-10-27 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 60,000 | 14.39 | 863,400 |
| 2016-10-17 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 41,666 | 84.39 | 3,516,235 |
| 2016-10-17 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 41,666 | 17.54 | 730,821 |
| 2016-10-14 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 11,000 | 86.89 | 955,812 |
| 2016-10-14 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 11,000 | 17.86 | 196,460 |
| 2016-10-13 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 53,125 | 86.97 | 4,620,546 |
| 2016-10-13 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 53,125 | 38.59 | 2,050,093 |
| 2016-09-30 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 53,125 | 92.02 | 4,888,775 |
| 2016-09-30 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 53,125 | 38.59 | 2,050,093 |
| 2016-09-29 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 53,125 | 93.64 | 4,974,890 |
| 2016-09-29 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 53,125 | 38.59 | 2,050,093 |
| 2016-09-27 | Ajer Jeffrey Robert (EVP, Chief Commercial Officer) | Sale | 18,467 | 95.61 | 1,765,648 |
| 2016-09-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 94,791 | 95.61 | 9,062,683 |
| 2016-09-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 94,791 | 28.07 | 2,660,309 |
| 2016-09-15 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 42,577 | 94.85 | 4,038,343 |
| 2016-09-15 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 42,577 | 17.33 | 737,859 |
| 2016-08-26 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 15,000 | 95.06 | 1,425,930 |
| 2016-08-26 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 15,000 | 26.49 | 397,350 |
| 2016-08-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 41,666 | 91.49 | 3,811,855 |
| 2016-08-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 41,666 | 17.54 | 730,821 |
| 2016-08-01 | Mueller Brian (VP, Corporate Controller) | Sale | 287 | 100.00 | 28,700 |
| 2016-08-01 | Davis George Eric (EVP, General Counsel) | Sale | 2,167 | 100.00 | 216,700 |
| 2016-08-01 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 4,000 | 99.33 | 397,320 |
| 2016-07-27 | Lawlis V Bryan | Sale | 1,100 | 95.39 | 104,926 |
| 2016-07-27 | Lawlis V Bryan | Option Ex | 1,100 | 17.33 | 19,062 |
| 2016-07-22 | Lawlis V Bryan | Sale | 6,400 | 95.01 | 608,064 |
| 2016-07-22 | Lawlis V Bryan | Option Ex | 6,400 | 17.33 | 110,911 |
| 2016-07-18 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 41,666 | 92.72 | 3,863,271 |
| 2016-07-18 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 41,666 | 17.54 | 730,821 |
| 2016-07-14 | Davis George Eric (EVP, General Counsel) | Option Ex | 2,656 | 38.59 | 102,495 |
| 2016-07-07 | Davis George Eric (EVP, General Counsel) | Sale | 2,167 | 90.00 | 195,030 |
| 2016-06-20 | Lawlis V Bryan | Sale | 1,650 | 82.77 | 136,569 |
| 2016-06-16 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 83,332 | 80.55 | 6,712,392 |
| 2016-06-16 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 83,332 | 17.54 | 1,461,642 |
| 2016-06-06 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 1,649 | 89.14 | 146,991 |
| 2016-05-31 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 20,841 | 89.67 | 1,868,916 |
| 2016-05-31 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Option Ex | 16,896 | 39.06 | 659,957 |
| 2016-05-26 | Fuchs Henry J (EVP, Chief Medical Officer) | Sale | 15,000 | 87.69 | 1,315,350 |
| 2016-05-26 | Fuchs Henry J (EVP, Chief Medical Officer) | Option Ex | 15,000 | 26.49 | 397,350 |
| 2016-05-23 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 3,769 | 87.08 | 328,185 |
| 2016-05-18 | Baffi Robert (EVP, Technical Operations) | Sale | 5,000 | 87.05 | 435,250 |
| 2016-05-10 | Davis George Eric (EVP, General Counsel) | Sale | 4,658 | 86.32 | 402,078 |
| 2016-05-09 | Davis George Eric (EVP, General Counsel) | Sale | 10,000 | 84.55 | 845,530 |
| 2016-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 50,000 | 80.15 | 4,007,450 |
| 2016-05-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 70,000 | 24.18 | 1,692,810 |
| 2016-05-02 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 36,500 | 85.01 | 3,102,938 |
| 2016-05-02 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 36,500 | 12.99 | 474,135 |
| 2016-04-06 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 14.39 | 21,585 |
| 2016-04-05 | Bienaime Jean Jacques (Chief Executive Officer) | Option Ex | 1,500 | 14.39 | 21,585 |
| 2016-03-14 | Davis George Eric (EVP, General Counsel) | Sale | 1,996 | 86.21 | 172,079 |
| 2016-03-04 | Ajer Jeffrey Robert (SVP, Chief Commercial Officer) | Sale | 1,255 | 88.42 | 110,970 |
| 2016-03-02 | Spiegelman Daniel K (EVP, Chief Financial Officer) | Sale | 4,623 | 86.12 | 398,118 |
| 2016-03-01 | Bienaime Jean Jacques (Chief Executive Officer) | Sale | 10,000 | 84.26 | 842,600 |
| 2016-02-22 | Grey Michael G | Sale | 7,500 | 80.00 | 600,000 |
| 2016-02-22 | Grey Michael G | Option Ex | 7,500 | 38.59 | 289,425 |
| 2015-12-16 | Davis George Eric (SVP, General Counsel) | Sale | 1,362 | 100.00 | 136,200 |
| 2015-11-16 | Lawlis V Bryan | Sale | 8,550 | 105.76 | 904,273 |
| 2015-11-16 | Lawlis V Bryan | Option Ex | 7,500 | 17.33 | 129,974 |
| 2015-11-16 | Grey Michael G | Sale | 7,500 | 104.27 | 782,055 |
| 2015-11-16 | Grey Michael G | Option Ex | 7,500 | 38.59 | 289,425 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN,
CIK number 1048477) see
the Securities and Exchange Commission (SEC) website.